Kathleen P. Gallagher serves as Executive at Avidity Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Kathleen P. Gallagher has executed 4 insider transactions totaling $8.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 17, 2025 involved selling 33,336 shares valued at $2.4M.
Kathleen P. Gallagher currently holds 88,868 shares of Avidity Biosciences, Inc. (RNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathleen P. Gallagher has been a net seller of RNA stock. They have purchased $0 and sold $8.9K worth of shares.
Kathleen P. Gallagher's most recent insider trade was on Dec 17, 2025, when they sold 33,336 shares at $71.87 per share.
Get notified when new Form 4 filings are submitted
| $71.87 |
| Discretionary |
| Dec 17, 2025 | RNA | $0 | Award | 72,000 | $N/A | Discretionary |
| Sep 2, 2025 | RNA | $8.9K | Sale | 188 | $47.42 | Discretionary |